- Filed
- Apr 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 10, 2025 | 5.8M sh |
| Cash And Equivalents | Q2 2025 · Feb 28, 2025 | $763 |
| Cash And Equivalents | Q2 2025 · Aug 31, 2024 | $546 |
| Stockholders Equity | Q2 2025 · Feb 28, 2025 | −$34.45K |
| Stockholders Equity | Q2 2025 · Nov 30, 2024 | −$20.02K |
| Stockholders Equity | Q2 2025 · Aug 31, 2024 | −$30.81K |
| Current Liabilities | Q2 2025 · Feb 28, 2025 | $180K |
| Current Liabilities | Q2 2025 · Aug 31, 2024 | $180.3K |
| Total Liabilities | Q2 2025 · Feb 28, 2025 | $180K |
| Total Liabilities | Q2 2025 · Aug 31, 2024 | $180.3K |
| Current Assets | Q2 2025 · Feb 28, 2025 | $763 |
| Current Assets | Q2 2025 · Aug 31, 2024 | $546 |
| Total Assets | Q2 2025 · Feb 28, 2025 | $145.55K |
| Total Assets | Q2 2025 · Aug 31, 2024 | $149.49K |
| Shares Diluted | Q2 2025 · Feb 29, 2024 | 4.5M sh |
| Shares Diluted | Q2 2025 · Feb 29, 2024 | 4.5M sh |
| Operating Cash Flow restated | Q2 2025 · Feb 29, 2024 | −$8.4K |
| Eps Diluted | Q2 2025 · Feb 29, 2024 | $0.00 |
| Eps Diluted restated | Q2 2025 · Feb 29, 2024 | $0.00 |
| Sga Expense restated | Q2 2025 · Feb 29, 2024 | $7.26K |
| Sga Expense restated | Q2 2025 · Feb 29, 2024 | $19.44K |
| Net Income restated | Q2 2025 · Feb 29, 2024 | −$4.36K |
| Net Income restated | Q2 2025 · Feb 29, 2024 | −$16.51K |
| Net Income | Q2 2025 · Nov 30, 2023 | −$12.16K |
| Operating Income restated | Q2 2025 · Feb 29, 2024 | −$4.36K |
| Operating Income restated | Q2 2025 · Feb 29, 2024 | −$16.54K |
| Gross Profit | Q2 2025 · Feb 29, 2024 | $2.9K |
| Gross Profit | Q2 2025 · Feb 29, 2024 | $2.9K |
| Revenue | Q2 2025 · Feb 29, 2024 | $2.9K |
| Revenue | Q2 2025 · Feb 29, 2024 | $2.9K |